A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neutropenia
Interventions: BIOLOGICAL: F-627 240 μg/kg|BIOLOGICAL: F-627 320 μg/kg
Sponsor: EVIVE Biotechnology
Collaborators: Fudan University|Sun Yat-sen University